Tuesday, June 7, 2016


Donato Perez Garcia
Hospital Angeles Tijuana


August 4-6, 1997, Bethesda , Maryland, Medical Hypotheses (20(2):199-210,1986) By: SGA, Donato Pérez García Bellón and Donato Pérez García , Jr.“Insulin Potentiation Therapy: a new concept for management of chronic degenerative disease”.
Radiother Oncol 2006;81(1):112-7
Jordan BF, Beghein N.Crokart N. et al.
“Preclinical safety and efficacy of insulin combined with irradiation”.
Cancer Chemotherapy and Pharmacology
” Insulin induced enhancement of antitumoral response to methotrexate in breast cancer patients”. Lasavio-Prosco E., Cucchi S., Vazquez J., Lasavio- Galante E., Golomar W., Gordon W.
The very first publication of IPT clinical trial data: “IPT very significantly improved clinical outcome of low dose of chemotherapy in patients with advance breast cancer”. December 4, 2003.
“The effect of insulin chemotherapeutic drug sensitivity in human esophageal and lung cancer cells”. Jiao SC, Huang J, Sun Y, Lu SX. Zhonghua Yi Xue Za Zhi.
February 2003.
10;83 (3):195-7 (article in Chinese)
“Insulin significantly enhanced the killing effect of three chemotherapy drugs on esophageal and lung cancer cell’s”.
Medical Hypotheses (2000) 55(4) 330-334, 2000
By: S.G.A, D.P. Garcia Bellon , D.P.Garcia Jr.
“Insulin chemotherapy and the mechanisms of malignancy: the design and the demise of cancer”.
October 1999, pages 94-96
M.D.M Townsend Letter for Doctors and Patients, S.G.A.
“Hoist by one’s own petard: the design and the demise of cancer”.
1981, European Journal of Cancer and Clinical Oncology 17(11):1223-1228.
Alabaster O., Vonderhaar B.K.,Ans Shafie S.M.,
“Metabolic modification by insulin enhances Methotrexate Cytotoxicity in MCF-7 human breast cancer cells”.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.